Cargando…

Efficacy of topical bevacizumab 0.05% eye drops in dry eye disease: A double-masked, randomized trial

The objective of this double-masked, placebo-controlled, randomized trial was to assess the efficacy and safety of bevacizumab 0.05% eye drops in dry eye patients. This study included Dry Eye Workshop Study (DEWS) Grade 3–4 dry eye participants (n = 31) whose tear break-up time (TBUT) was ≤5 seconds...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kasetsuwan, Ngamjit, Chantaralawan, Kanawat, Reinprayoon, Usanee, Uthaithammarat, Lita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7274382/ https://www.ncbi.nlm.nih.gov/pubmed/32502179 http://dx.doi.org/10.1371/journal.pone.0234186

Ejemplares similares

Lack of HPV in pterygium with no evidence of autoinoculation and the role of cytokines in pterygium with dry eye
por: Uthaithammarat, Lita, et al.
Publicado: (2021)

Efficacy of Interleukin-1β Inhibitor on Dry Eye Disease in Patients with Degenerative Arthritis
por: Treewipanon, Nathapon, et al.
Publicado: (2023)

Author Correction: Lack of HPV in pterygium with no evidence of autoinoculation and the role of cytokines in pterygium with dry eye
por: Uthaithammarat, Lita, et al.
Publicado: (2021)

Effectiveness and Safety of Combined Application of Three Modes of 2940-nm Erbium:YAG and 1064-nm Neodymium:YAG Lasers in Treatment of Meibomian Gland Dysfunction
por: Kasetsuwan, Ngamjit, et al.
Publicado: (2021)

Dry Eye Disease in Hemifacial Spasm Patients Treated with Botulinum Toxin Type A
por: Jariyakosol, Supharat, et al.
Publicado: (2021)

Alteration of corneal biomechanical properties in patients with dry eye disease
por: Satitpitakul, Vannarut, et al.
Publicado: (2021)

Efficacy of topical cyclosporine 0.05% and osmoprotective lubricating eye drops in treating dry eye disease and inflammation
por: Mullick, Ritika, et al.
Publicado: (2021)

Cyclosporine (0.05%) Combined with Diclofenac Sodium Eye Drops for the Treatment of Dry Eye Disease
por: Bai, Run, et al.
Publicado: (2022)

Efficacy of Topical Cyclosporine Nanoemulsion 0.05% Compared with Topical Cyclosporine Emulsion 0.05% and Diquafosol 3% in Dry Eye
por: Park, Chang Hyun, et al.
Publicado: (2019)

Bevacizumab Eye Drops Vs. Intra-meibomian Gland Injection of Bevacizumab for Meibomian Gland Dysfunction-Associated Posterior Blepharitis
por: Tantipat, Chitchanok, et al.
Publicado: (2022)

The Effect of Topical Cyclosporine 0.05% on Dry Eye after Cataract Surgery
por: Chung, Yeon Woong, et al.
Publicado: (2013)

Descemet’s scroll in syphilitic interstitial keratitis: a case report with anterior segment evaluation and a literature review
por: Kasetsuwan, Ngamjit, et al.
Publicado: (2015)

Rate of Cornea Endothelial Cell Loss and Biomechanical Properties in Fuchs' Endothelial Corneal Dystrophy
por: Reinprayoon, Usanee, et al.
Publicado: (2021)

Intraocular Implantable Collamer Lens with a Central Hole Implantation: Safety, Efficacy, and Patient Outcomes
por: Wannapanich, Trakanta, et al.
Publicado: (2023)

Recurrent rates and risk factors associated with recurrent painful bullous keratopathy after primary phototherapeutic keratectomy
por: Kasetsuwan, Ngamjit, et al.
Publicado: (2015)

The Efficacy Between Conventional Lid Hygiene and Additional Thermal Pulsatile System in Meibomian Gland Dysfunction Patients Treated with Long-Term Anti-Glaucoma Medications in a Randomized Controlled Trial
por: Kasetsuwan, Ngamjit, et al.
Publicado: (2020)

Cyclosporine a 0.05% eye drops for the treatment of subepithelial infiltrates after epidemic keratoconjunctivitis
por: Okumus, Seydi, et al.
Publicado: (2012)

Efficacy and safety of topical cyclosporine 0.1% in moderate-to-severe dry eye disease refractory to topical cyclosporine 0.05% regimen
por: Chan, Yuan-Hsi, et al.
Publicado: (2023)

Incidence and Pattern of Dry Eye after Cataract Surgery
por: Kasetsuwan, Ngamjit, et al.
Publicado: (2013)

Effectiveness of voriconazole and corneal cross-linking on Phialophora verrucosa keratitis: a case report
por: Taechajongjintana, Marisa, et al.
Publicado: (2018)

A study of refractory cases of persistent epithelial defects associated with dry eye syndrome and recurrent corneal erosions successfully treated with cyclosporine A 0.05% eye drops
por: Napoli, Pietro Emanuele, et al.
Publicado: (2019)

Combination of 0.05% Azelastine and 0.1% Tacrolimus Eye Drops in Children With Vernal Keratoconjunctivitis: A Prospective Study
por: Chen, Minjie, et al.
Publicado: (2021)

Topometric Indices And Corneal Densitometry Change After Corneal Refractive Surgery Combined With Simultaneous Collagen Crosslinking
por: Piyacomn, Yonrawee, et al.
Publicado: (2019)

Survival Outcome and Prognostic Factors of Corneal Transplantation: A 15-Year Retrospective Cohort Study at King Chulalongkorn Memorial Hospital
por: Reinprayoon, Usanee, et al.
Publicado: (2021)

Keratoconus in Thai population – a cross-sectional hospital-based study
por: Piyacomn, Yonrawee, et al.
Publicado: (2023)

Assessing the Risk Factors For Diagnosed Symptomatic Dry Eye Using a Smartphone App: Cross-sectional Study
por: Kasetsuwan, Ngamjit, et al.
Publicado: (2022)

Effectiveness and Optical Quality of Topical 3.0% Diquafosol versus 0.05% Cyclosporine A in Dry Eye Patients following Cataract Surgery
por: Lee, Jang Hoon, et al.
Publicado: (2016)

Patient and physician perspectives on the use of cyclosporine ophthalmic emulsion 0.05% for the management of chronic dry eye
por: Deveney, Tatiana, et al.
Publicado: (2018)

PERSIST: Physician’s Evaluation of Restasis(®) Satisfaction in Second Trial of topical cyclosporine ophthalmic emulsion 0.05% for dry eye: a retrospective review
por: Mah, Francis, et al.
Publicado: (2012)

Cyclosporine A (0.05%) Ophthalmic Gel in the Treatment of Dry Eye Disease: A Multicenter, Randomized, Double-Masked, Phase III, COSMO Trial
por: Peng, Wenyan, et al.
Publicado: (2022)

Cyclosporine 0.05% Ophthalmic Emulsion for Dry Eye in Korea: A Prospective, Multicenter, Open-Label, Surveillance Study
por: Byun, Yong-Soo, et al.
Publicado: (2011)

A murine model of dry eye induced by topical administration of erlotinib eye drops
por: Yang, Qi-Chen, et al.
Publicado: (2018)

1165. Epidemiology, management and outcomes of fungal keratitis: A single center study from tertiary hospital in Thailand
por: Puttiteerachot, Thitiwat, et al.
Publicado: (2020)

Effectiveness of a participatory eye care program in reducing eye strain among staff computer users in Thailand
por: Lertwisuttipaiboon, Sudaw, et al.
Publicado: (2017)

A randomized multicenter evaluation of the efficacy of 0.15% hyaluronic acid versus 0.05% cyclosporine A in dry eye syndrome
por: Lee, Ji Eun, et al.
Publicado: (2022)

Comparison of 0.05% cyclosporine and 3% diquafosol solution for dry eye patients: a randomized, blinded, multicenter clinical trial
por: Park, Chang Hyun, et al.
Publicado: (2019)

Safety and efficacy of switching from dorzolamide 1.0%/timolol maleate 0.5% eye drops to brinzolamide 1.0%/timolol maleate 0.5% eye drops
por: Inoue, Kenji, et al.
Publicado: (2015)

A Randomized Multicenter Study Comparing 0.1%, 0.15%, and 0.3% Sodium Hyaluronate with 0.05% Cyclosporine in the Treatment of Dry Eye
por: Park, Yuli, et al.
Publicado: (2017)

Efficacy and Safety of Topical Calcipotriol 0.005% Versus Topical Clobetasol 0.05% in the Management of Alopecia Areata: An Intrasubject Pilot Study
por: Molinelli, Elisa, et al.
Publicado: (2020)

The effect of topical 0.05% cyclosporine on recurrence following pterygium surgery
por: Turan-Vural, Ece, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_drdv1bsimhd587573fiurfu79e